Janody D, Droulle C, Adjizian J C, Ostermann G, Poynard J P, Jeunehomme G, Leutenegger M, Potron G
J Mal Vasc. 1982;7(3):221-4.
Both micro and macro-angiopathy involve interaction of blood vessel and plasma factors which may be altered in diabetes. Little is known concerning changes in contact and fibrinolysis factors as prekallikrein, plasminogen and fast antiplasmin in diabetes. We tested also the plasminogen/antiplasmin ratio in 151 diabetics and 64 normal subjects (18 to 74 years old). Our conclusion is:--the absence of correlation between the clinical characteristic of diabetes and prekallikrein level,--the decrease of plasminogen/antiplasmin ratio in complicated diabetes,--in complicated diabetes, correlation between antithrombin III, VIII factor and fibrinogen levels, perhaps, in relation with inflammation signs.
微血管病变和大血管病变均涉及血管与血浆因子的相互作用,而这些因子在糖尿病中可能会发生改变。关于糖尿病患者中接触因子和纤溶因子(如前激肽释放酶、纤溶酶原和快速抗纤溶酶)的变化,我们知之甚少。我们还检测了151名糖尿病患者和64名正常受试者(年龄在18至74岁之间)的纤溶酶原/抗纤溶酶比值。我们的结论是:——糖尿病的临床特征与前激肽释放酶水平之间不存在相关性;——在糖尿病并发症患者中,纤溶酶原/抗纤溶酶比值降低;——在糖尿病并发症患者中,抗凝血酶III、VIII因子和纤维蛋白原水平之间存在相关性,这可能与炎症迹象有关。